Quince Therapeutics (QNCX) Accumulated Depreciation (2018 - 2026)
Quince Therapeutics (QNCX) posted quarterly Accumulated Depreciation of $856000.0 for Q1 2026, up 1.42% quarter-over-quarter from $844000.0 in Q4 2025.
Quince Therapeutics (QNCX) Accumulated Depreciation (2018 - 2026) Analysis & Trends
Quince Therapeutics' Accumulated Depreciation history runs 9 years deep, the most recent figure standing at $856000.0 for Q1 2026.
- In Q1 2026, Accumulated Depreciation changed N/A year-over-year to $856000.0; the TTM figure through Mar 2026 stood at $856000.0 (changed N/A YoY), while the FY2025 annual figure was $844000.0, up 32.08% from the prior year.
- Accumulated Depreciation for Q1 2026 stood at $856000.0, up from $844000.0 in the prior quarter.
- The five-year high for Accumulated Depreciation was $996000.0 in Q1 2022, with the low at $12000.0 in Q1 2023.
- The 5-year median for Accumulated Depreciation is $518500.0 (2023), against an average of $465714.3.
- The sharpest annual moves came in 2023 and 2024: Accumulated Depreciation sank 98.8% in 2023, then surged 4316.67% in 2024.
- Quince Therapeutics' Accumulated Depreciation stood at $185000.0 in 2022, then surged by 174.05% to $507000.0 in 2023, then rose by 26.04% to $639000.0 in 2024, then jumped by 32.08% to $844000.0 in 2025, then increased by 1.42% to $856000.0 in 2026.
- Business Quant data shows QNCX's Accumulated Depreciation at $856000.0 in Q1 2026, $844000.0 in Q4 2025, and $807000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Quince Therapeutics | 203.43 Mn | 203.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 856,000.00 |
| Dec 31, 2025 | 844,000.00 |
| Sep 30, 2025 | 807,000.00 |
| Jun 30, 2025 | 777,000.00 |
| Dec 31, 2024 | 639,000.00 |
| Mar 31, 2024 | 530,000.00 |
| Dec 31, 2023 | 507,000.00 |
| Sep 30, 2023 | 13,000.00 |
| Jun 30, 2023 | 12,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 185,000.00 |
| Sep 30, 2022 | 159,000.00 |
| Jun 30, 2022 | 183,000.00 |
| Mar 31, 2022 | 996,000.00 |
| Dec 31, 2021 | 959,000.00 |
| Sep 30, 2021 | 875,000.00 |
| Jun 30, 2021 | 788,000.00 |
| Mar 31, 2021 | 701,000.00 |
| Dec 31, 2020 | 615,000.00 |
| Sep 30, 2020 | 530,000.00 |